Phase II Trial of Phillips MRI-Guided High Intensity Focused Ultrasound (Sonalleve) and Lyso-thermosensitive Liposomal Doxorubicin (ThermoDox) for Palliation of Painful Bone Metastases

Trial Profile

Phase II Trial of Phillips MRI-Guided High Intensity Focused Ultrasound (Sonalleve) and Lyso-thermosensitive Liposomal Doxorubicin (ThermoDox) for Palliation of Painful Bone Metastases

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Doxorubicin liposomal (Primary)
  • Indications Advanced breast cancer; Bone metastases; Cancer pain; Non-small cell lung cancer; Prostate cancer; Small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Celsion Corporation
  • Most Recent Events

    • 04 Mar 2016 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
    • 21 Jul 2014 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.
    • 18 Jul 2012 Status changed from planning to not yet recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top